Publication | Closed Access
Induction Therapy With Biosimilar Infliximab in Children With Crohn Disease
33
Citations
26
References
2017
Year
Induction therapy with CT-P13 in children with CD is effective. The profile appears similar to that reported for the reference infliximab. No unexpected adverse events occurred.
| Year | Citations | |
|---|---|---|
Page 1
Page 1